Mutilating hereditary sensory neuropathy with spastic paraplegia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:139578OMIM:256840G60.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Mutilating hereditary sensory neuropathy with spastic paraplegia is an extremely rare genetic disorder that combines two major neurological features: a severe sensory neuropathy leading to progressive mutilation of the extremities, and spastic paraplegia affecting the lower limbs. The sensory neuropathy component results in a profound loss of pain and temperature sensation, particularly in the hands and feet. Because affected individuals cannot feel injuries, they are prone to recurrent wounds, infections, and progressive tissue damage (ulcerations, osteomyelitis, and eventual auto-amputation of digits), which is referred to as the "mutilating" aspect of the disease. The spastic paraplegia component involves progressive stiffness and weakness of the legs due to upper motor neuron dysfunction, leading to difficulty walking and impaired mobility. The condition primarily affects the peripheral nervous system (sensory nerves) and the central nervous system (corticospinal tracts). Clinical features typically include distal sensory loss, acromutilation, trophic ulcers of the feet, lower limb spasticity, hyperreflexia, and extensor plantar responses. Some patients may also develop urinary disturbances. The disease is progressive, and management is largely supportive, focusing on prevention of injuries and infections through meticulous foot care and wound management, orthopedic interventions when needed, and physical therapy to address spasticity. Antispasticity medications such as baclofen may be used to manage lower limb stiffness. There is currently no curative treatment available for this condition.

Also known as:

Clinical phenotype terms— hover any for plain English:

Acral ulcerationHP:0006121Distal sensory impairment of all modalitiesHP:0003409Abnormal spinal cord morphologyHP:0002143Sensory axonal neuropathyHP:0003390Decreased motor nerve conduction velocityHP:0003431Foot osteomyelitisHP:0001886
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Mutilating hereditary sensory neuropathy with spastic paraplegia.

View clinical trials →

No actively recruiting trials found for Mutilating hereditary sensory neuropathy with spastic paraplegia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Mutilating hereditary sensory neuropathy with spastic paraplegia community →

No specialists are currently listed for Mutilating hereditary sensory neuropathy with spastic paraplegia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Mutilating hereditary sensory neuropathy with spastic paraplegia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Mutilating hereditary sensory neuropathy with spastic paraplegiaForum →

No community posts yet. Be the first to share your experience with Mutilating hereditary sensory neuropathy with spastic paraplegia.

Start the conversation →

Latest news about Mutilating hereditary sensory neuropathy with spastic paraplegia

No recent news articles for Mutilating hereditary sensory neuropathy with spastic paraplegia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Mutilating hereditary sensory neuropathy with spastic paraplegia

What is Mutilating hereditary sensory neuropathy with spastic paraplegia?

Mutilating hereditary sensory neuropathy with spastic paraplegia is an extremely rare genetic disorder that combines two major neurological features: a severe sensory neuropathy leading to progressive mutilation of the extremities, and spastic paraplegia affecting the lower limbs. The sensory neuropathy component results in a profound loss of pain and temperature sensation, particularly in the hands and feet. Because affected individuals cannot feel injuries, they are prone to recurrent wounds, infections, and progressive tissue damage (ulcerations, osteomyelitis, and eventual auto-amputation

How is Mutilating hereditary sensory neuropathy with spastic paraplegia inherited?

Mutilating hereditary sensory neuropathy with spastic paraplegia follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.